chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DX COVID 19 pneumonia, hypoxia. Patient presents to the ED secondary to a reported 4 day history of general malaise, weakness, shortness of breath.On arrival here, satting 87% on room air. Patient has increased work of breathing, very poor historian, unable to further elaborate. Reports productive cough, with occasional white/yellow sputum production. Reports associated nausea but no vomiting. Also reports diarrhea. dimer 403. PLts 104.  Received IV decadron. Breo inhaler, albuterol nebulizer. Supplemental oxygen. IV antibiotics. treated with IV remdesivir and IV steroid with breathing treatment and also with po oluminate ,  Patient blood bradyarrhythmia most likely related to remdesivir and beta-blocker.  Patient condition continued to be deteriorating and patient was intubated and placed on full vent support and transferred to the ICU.  Patient also treated for pneumonia with broad-spectrum IV antibiotic but the patient condition continued to be to deteriorating and patient expired
about about 10 min after receiving two vaccines patient felt light-headed, eyes heavy. she returned to IMZ area and like she would faint. we provided aid to help her recover and after about 15-20 min she felt fine.
Fever - Between 3am on 4/13/2021 until 5:30pm 4/13/2021 muscle aches - Started 6am 4/13/2021 and still happening headache - Started after vaccine and still happening Treatment for all three is switching acetaminophen and ibuprofen
10cm area of redness, increased warmth and induration noted at injection site in left deltoid.
About 11 days after receiving the Moderna booster, my body began to itch all over. Scratching seemed to aggravate my skin and within minutes my skin became raised, turned red, and looked like I had developed hives. If I managed not to itch the area for about an hour, it would largely disappear and sometimes outright stop itching. The condition seemed to match the symptoms of Dermatographia. In the first few days - although the itching was all over - I recall it was worse in my palms and feet.  The first week I tried to combat with Allegra 180mg 24/7 allergy relief pill, which I continue to take 180mg of daily to-date. I received a 6 day steroid program of METHYLPREDNISOLONE 4 MG DOSEPK tablets from my primary care doctor, which helped reduce the effect of raised skin / hives / itching, although it had only a minor impact on my skin turning red from any pressure/scratching (affected areas didn't turn quite as red and disappeared faster).  It has now been about 4 weeks since the symptoms began. The 6-day METHYLPREDNISOLONE treatment ended over a week ago. I am still noticing sporadic itching and consistently noticing red marks where and pressure/scratching occurred, even if there isn't itching. It is not consistently as bad as it initially was, but far from gone, and sometimes it flares up to a point that seems just as bad (even though it is less often). Just yesterday, light contact with my stomach while in bed cause it to start itching and I found raised red marks all over within 15 minutes -- again resembling Dermatographia or something similar.  A lesser symptom, but during this time, I also noticed a discomfort in my throat that felt a little like something small was stuck in it, and occasionally noticed mild chest tightening, although nothing that had a measurable impact on my life. This has declined over time.   My primary care doctor stated they have seen similar symptoms in other patients in the last few months and that the vaccine seemed to be a common denominator, although they stated that this was not a confirmed / known side effect yet.
Began to have problems with muffled hearing in both ears shortly after receiving this shot (my first booster).  Reported it to my primary care doctor in early July 2022 when I saw her for my regular checkup.  She prescribed Azelastaine nose spray, which did not help.  Have also taken Sudafed with little impact.  Finally saw my Ear, Nose and Throat doctor on 2/9/2023.  He prescribed steroids, which did not help.  Neither doctor has related my hearing problems to the vaccination, but I have since heard other people report that they are experiencing the same hearing problems I am.  All say that their problems began after receiving the Moderna booster.  So while I have no proof that my hearing problems are related to the vaccine, I want to register this adverse effect as a possibility.  My muffled hearing has not responded to any treatment and I am very frustrated.   I have tried to look at your adverse effect database to see how many others have reporting hearing loss, but it is very difficult to use.
Patient fainted within 10 minutes of receiving vaccine while in the post vaccine wait/observation area. Pharmacist responded immediately, patient regained consciousness immediately, and reported no side effects afterwards. Patient remained in observation for 30 minutes following incident.
Patient has a normal resting heart rate of approximately 60-65 bpm.  The day after receiving the Pfizer covid vaccine, heart rate dropped to 25 bpm, and patient passed out.  Heart rate remained between 30-40 bpm for approximately 1 1/2 hours.  Patient continued to experience a low heart rate of approximately 45-50 bpm for a week, as well as swollen lymph nodes and mild chest pain.  As the swollen lymph nodes resolved over the week, patient's resting heart rate started to get back to the normal 60-65 bpm.  Patient reported to internal medicine clinic on May 7, 2021.  Blood test performed on May 8, 2021 - results normal.  Echocardiogram and halter monitor performed on May 24, 2021 - results normal.  Cardiology visit on June 2, 2021.  Cardiology suspected possible myocarditis, vagus nerve stimulation, and/or allergic reaction as result of first dose of vaccine.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical histories, concomitant medications and drug reactions or allergies were not reported. From 16-FEB-2017 to 16-MAR-2017, a four of improperly stored doses of VAQTA injection (lot # M033611 with expiration date at 02-MAR-2018; dose and route of administration were not reported) were administered to the patients, for prophylaxis. The administered doses of vaccine were exposed to a temperature between 47 degrees Fahrenheit (F) to 77 degrees Fahrenheit (F) for 45 minutes. Data logger was used to track the temperature. No previous temperature excursion was reported. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Jab 5pm; 11pm brief dizziness, slight headache (rare for me); 5am diarrhea for 3 hours; very tired for two days, on/off headache; next  four days woke before dawn to very strong heart palpitations... jumping heart... each time soon following with strong headache; I could at strongest beats see the beats through 'flashes' in my eyes; standing or walking to bathroom felt faint, sometimes wondering if will pass out; always begins while lying down; sleeping on both sides, on back the same; sitting in chair seemed to eventually help; once up and eventually more active palpitations have settled down to a few 'reminders' during the day and evening. Fear going to bed now., eleven days after 2nd Moderna.
Sinus infection, chest congestion, stomach pain/acid, lung issues-asthma like, high eosinophilia, tinnitus and loss of taste/smell
04/08 15min after injection, got breath difficulty that lasts for 1hr 04/09 Intense fatigue, muscle ache and dizziness  whole day 04/10 Symptoms cease to exist 04/12 Early in the morning: Left arm and hand numbness with ache , head numbness; Noon: getting better; Evening: left leg and feet numbness, face and head numbness; Night: head numbness and nausea, left arm and hand numbness 04/13 Head numbness, left arm and hand numbness, left leg numbness
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown demographics. The patient's current conditions or medical history were not reported. On 17-MAR-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 vial, intramuscular, 0.5 ml expiry date 11-MAR-2014 (lot number was not reported). No adverse effect reported. Additional information is not expected.
Vaccine was administered around 5 PM on 1/14/2021. Chest pain started around 9 PM the same day and continued, also had some shortness of breath. Headed to emergency room around 4 AM on 1/15/2021. Several tests were done, found general systemic inflammation. Chest pain caused by inflammation in lungs and airways. Treated with ibuprofen and chest pain cleared in about 40 minutes. Discharged at 1/15/2021 around 7 AM.
Information has been received from a physician concerning a 6 year old male who on 09-MAY-2002 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (Lot # 641264/1180L). In October or November 2006 the patient experienced a full blown case of chickenpox. The number of lesions on patient's body was unknown. Unspecified medical attention was sought. At the time of the report the patient had recovered. A product quality complaint was not involved. No further information is available. It was also reported that the patient's sister had a similar experience after therapy with varicella virus vaccine live (Oka/Merck) (WAES # 0704USA06478).
headache; Pain in both eyes above the eye lids; trouble breathing; body aches; Left side hurts from my head to my big toe; obstruction in my throat; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), EYE PAIN (Pain in both eyes above the eye lids), DYSPNOEA (trouble breathing), MYALGIA (body aches) and PAIN (Left side hurts from my head to my big toe) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), EYE PAIN (Pain in both eyes above the eye lids), DYSPNOEA (trouble breathing), MYALGIA (body aches), PAIN (Left side hurts from my head to my big toe) and DYSPHAGIA (obstruction in my throat). At the time of the report, HEADACHE (headache), EYE PAIN (Pain in both eyes above the eye lids), DYSPNOEA (trouble breathing), MYALGIA (body aches), PAIN (Left side hurts from my head to my big toe) and DYSPHAGIA (obstruction in my throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
swelling lymph node in right armpit; below 50 years old patient received shingrix; This non-serious case was reported by a consumer via call center representative and described the occurrence of axillary lymph nodes enlarged in a 38-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE for prophylaxis.   On 28-SEP-2023, the patient received Shingrix (right arm) and INFLUENZA VACCINE (right arm). On 28-SEP-2023, an unknown time after receiving Shingrix, the patient experienced inappropriate age at vaccine administration (Verbatim: below 50 years old patient received shingrix). On an unknown date, the patient experienced axillary lymph nodes enlarged (Verbatim: swelling lymph node in right armpit).  The outcome of the axillary lymph nodes enlarged was not resolved and the outcome of the inappropriate age at vaccine administration was unknown.   It was unknown if the reporter considered the axillary lymph nodes enlarged to be related to Shingrix.     It was unknown if the company considered the axillary lymph nodes enlarged to be related to Shingrix.   Additional Information: GSK Receipt date: 03-OCT-2023 The patient was self-reported.  The patient stated she received Shingrix and Flu vaccine (from Sanofi-pasteur manufacturer) on 28 September 2023 in her right arm and since them she noticed swelling lymph nodes in her right armpit. It was unknown if the reporter considered the axillary lymph nodes enlarged to be related to Flu vaccine.   38 years old patient received Shingrix which led to inappropriate age at vaccine administration. The reporter did not consent to follow-up.
No additional AE information provided.; the product was diluting the PEDVAXHIB with 0.5mL of normal saline and then drawing up 0.5mL; the product was diluting the PEDVAXHIB with 0.5mL of normal saline and then drawing up 0.5mL; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 10-AUG-2022, the patient was vaccinated with the second dose of haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5 mL (route of administration was not provided) lot # W002453, expiration date: 24-JUN-2024, administered as prophylaxis which was accidentally diluted with 0.5 mL of normal saline (Incorrect dose administered) (Product preparation error). No additional adverse event (AE) information provided.  This is one of several cases received from the same reporter.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 09-SEP-2013, the patient was vaccinated with VARIVAX (Merck) (dose strength and route was not reported) (lot # H018455 and expiry date: 09-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting VARIVAX (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
A few days after my first dose on 2/9/2021, rash started to appear on my back and front of body . After my 2nd dose 3/9/2021, the rash became a lot worse and mostly on my back. Rash was very itchy and I used Clobetasol for relief. . My primary doctor prescribed me two separate Prednisone treatments . The first treatment in May 2021 was for 7 days and a few months later in August for 25 days. Rash did not go away.
Pt 2 wks after MMR/Varicella developed full blown TIP w/ platelets down to 4K! Referred to Hematologist.
5 minutes later - perfuse sweating, entire body hot, dizzy, elevated pulse and BP 147, heart palpitations; drank a juice & some water 10 minutes later - sweats/chills, still dizzy, BP decreasing 135, agitated 20 minutes later - still sweating,/chills, head clearing, heart palpitations subsiding,  Tired, legs/body very heavy.  Dizzy when walking, told to rest longer 30 minutes - still sweating/chills, could only walk short distance with heavy legs and dizziness, told to rest longer 40 minutes - massive headache, slight dizziness, continued leg heaviness. nausea, light sensitive, very itchy arm. Did not feel better until 11:30 PM that night Woke in the morning with just a sore arm, runny nose and an over-all fatigue, a little cough
Case number PHEH2014US024985 is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 39-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 17 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
numbness in her mouth and shoulder; numbness in her mouth and shoulder; blurry vision; elevated pressure; her arm became painful; sharp pain in the middle of the chest; This is a spontaneous report from a contactable consumer reported for self. This female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Jan2021 15:30 pm at single dose for covid-19 immunisation.  Medical history included rib surgery last Sep2020. She had an episode on Friday morning 08Jan2021 with a sharp pain in the middle of the chest that was so bad she had to take Ibuprofen and lie down with a heating pad to her chest. After that, she had numbness in her mouth and shoulder, and had blurry vision to which she had her son call 911. As the EMTs arrived they recorded her with elevated pressure and took a cardiogram which reported everything was 'perfect', no stroke, no heart attack. She mentioned that she had a rib surgery last Sep2020 and was still healing and took pressure medication for it, She mentioned that the EMTs told her to take the medication in the morning and not in the afternoon and that the episode was not related to the vaccine. She also reported that her arm became painful for a day after the injection but it did not cause her anything else. She knows that other ladies who received the vaccine in her building had flu-like symptoms and was asking if her symptoms were reported for the vaccine. Patient mentioned that she was calling to report her side effects and that she will receive the 2nd dose on 26Jan2021. Outcome of the events was unknown.  Information about lot/batch number has been requested.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Additional Details: Patient faint for around 1 minute or less. 911 was called. Patient was countious when they arrived but was still feeling weak and had nausea. They were taking the patient to an emergency room.
10MAY91 PT recd vax; 2 hrs p/vax exp dizziness which lasted 2-3 hrs & PT "could not move"; no rx; PT recovered p/3 hrs;
The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.).    No concomitant medication was reported.   Suspect product dosage text was reported as unknown. The vial did not undergo any temperature excursions. Suspect vaccine expiry date was 11-May-2023.  It was reported that no adverse reactions have been reported by any patients.  No treatment medication was reported.  This case is reported for patient 30th out of 50 adult patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)
About 3 hours after receiving the first dose, my right eye began to itch but there wasn't any thing physically seen on the day I received the vaccine. When I woke up the next morning on Friday, May 28th, I noticed my eyelid (the part that's closer to the lashes) had swollen up. Saturday morning, it had swollen more than it had the previous day. I tried placing a hot wash cloth over my eye. My eyelid was super tender and the slightest touch to the eyelid hurt. Sunday, I decided to make it to the ER. Although they couldn't confirm that it was an allergic reaction (even though I told them it was), the doctor saw how it was swollen and tender. I was given 3 different medications to take. It is now day 5 and it seems as though it has worsened because it's now the whole eyelid. It's painful. When I had to get something off the floor or tie my shoe, it feels like drainage is rushing towards the front of my head and causing the pain in my eye.
Wife diagnosed with COVID 2 days prior to my symptoms; My symptoms were - headache, nasal congestion, slight cough, felt bad all over, fever;
Within 15 minutes right facial numbness and eyelid swelling, mild  lid droop, lasted 4 hours
Heart issues- too fast-too slow, missing beats, skipping beats.  Taken to ER by nurse on duty.
Wheezing, difficulty breathing, extreme nonstop coughing, swelling of mouth and face, hoarseness, weakness, sweating, phlegm
1055: Patient in 15 minute observation called for medical with c/o dizziness and diaphoretic. Patient taken to first aid station for further assessment by Physician and EMS on Duty.
Generalized  maculopapular rash on all limbs and torso.after third Pfizer shot. Started after 24 hours from injection. No reaction to fist two injections.
Area of redness  approximately 1 1/2" by 1 1/2" on LVLM with slight swelling, pain and warmth to touch. Advised to use cold compress and give Tylenol. By 8/2/2019 redness, swelling and warmth and pain was going down. As of 8/5/2019 area completely clear.